Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
We report the fourth described case of severe toxic rhabdomyolysis occurring in an 81-year-old woman caused by the concomitant administration of palbociclib taken at the usual dosage (125 mg per day) and simvastatin. To the best of our knowledge, this is the first reported case successfully treated...
Main Authors: | François Poumeaud, Anna Fontanier, Jérémie Dion, Quentin Mathevet, Olivier Cointault, Emmanuelle Uro-Coste, Céline Marty, Florence Dalenc, Pierre Girardie, Anaïs Rataboul |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1026434/full |
Similar Items
-
Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
by: François Poumeaud, et al.
Published: (2023-02-01) -
Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report
by: Vardan Nersesjan, et al.
Published: (2019-10-01) -
An undifferentiated cause of rhabdomyolysis: a case report
by: Pallavi Patil, et al.
Published: (2023-05-01) -
Myositis and rhabdomyolysis in scrub typhus infection: A case report
by: Tukaram Bolla, et al.
Published: (2023-01-01) -
Study of the mutation causing type 1 polysaccharide storage myopathy in a Mangalarga Marchador population used in breeding programs
by: Nayne Vieira da Silva, et al.
Published: (2023-06-01)